Niowave, Ratio Therapeutics Sign Actinium-225 Supply Agreement to Advance Targeted Alpha Therapies

Niowave and Ratio Therapeutics have signed a supply agreement for Actinium-225, strengthening Ratio’s access to a ...

June 17, 2026 | Wednesday | News
Why Donor Supply Chains May Decide the Future of Cell Therapy Commercialisation

As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...

June 15, 2026 | Monday | News
SCbio Highlights South Carolina’s Life Sciences Growth at BIO 2026

SCbio will spotlight South Carolina’s expanding life sciences sector at BIO International Convention 2026 in San D...

June 12, 2026 | Friday | News
Korea's Daewoong Pharma partners with China's Chime Biologics for Dupixent biosimilar development

Chime Biologics, a China-based biologics CDMO dedicated to enabling partners’ success, and South Korea-based Daewo...

June 5, 2026 | Friday | News
“Scalable manufacturing for high-volume siRNA programmes remains underdeveloped”

What were the key takeaways for Hongene after attending TIDES USA 2026? TIDES USA 2026 reinforced several themes that w...

June 2, 2026 | Tuesday | Opinion
CDMOs & ATMP Growth Upswing in APAC

The rise of advanced therapies is fundamentally reshaping the contract manufacturing landscape, pushing CDMOs to evolve ...

June 2, 2026 | Tuesday | Analysis
Korea's LOTTE Biologics expands antibody manufacturing deal with Ottimo Pharma

South Korea-based LOTTE Biologics has announced an expansion of its collaboration with UK-based Ottimo Pharma, an innova...

May 18, 2026 | Monday | News
Vetter starts construction of new facility in Germany for production of injectable drugs

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has announced the start of constructi...

May 14, 2026 | Thursday | News
Taiwan's Bora Group buys MacroGenics' GMP manufacturing operations for $122.5 M

Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of the GMP manufact...

May 12, 2026 | Tuesday | News
AI Tools Life Sciences Companies Are Using

AI is now firmly embedded across the pharmaceutical value chain, from drug discovery to clinical research and manufactur...

May 1, 2026 | Friday | Opinion
Quasar Medical announces opening of new manufacturing facility in Thailand

Quasar Medical, a global leader in the manufacturing of interventional and minimally invasive medical devices, has annou...

April 26, 2026 | Sunday | News
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing

Andelyn Biosciences, a US-based cell and gene therapy Contract Development and Manufacturing Organization (CDMO), and EN...

April 22, 2026 | Wednesday | News
Aragen launches ‘ChemiSHE’, India’s first women-led chemistry synthesis laboratory

Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has launched Chemi...

April 13, 2026 | Monday | News
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment

Cartherics, an Australia-based biotechnology company developing off‑the‑shelf immune cell therapies for high‑impac...

April 10, 2026 | Friday | News
Lonza Redefines Bioprocess Efficiency In APAC With Advanced Media Development Lab

  As biologics pipelines grow more complex and timelines tighten, early stage process decisions are becoming criti...

April 9, 2026 | Thursday | Opinion
NJ Bio collaborates with Ajinomoto Bio‑Pharma to strengthen support for ADC development

US-based NJ Bio, Inc., a leading provider of integrated drug discovery and development services and Japan's Ajinomoto Bi...

April 2, 2026 | Thursday | News
Celltrion announces KRW 1.2 T expansion of new DS production facilities in Songdo

South Korea-based Celltrion plans to secure additional manufacturing capacity through a large-scale expansion investment...

March 30, 2026 | Monday | News
Lonza opens Media Development Lab in Singapore for cell culture media optimisation

Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), has announced th...

March 27, 2026 | Friday | News
Australia's Clarity inks large-scale manufacturing supply agreement for copper-64 with Theragenics

Clarity Pharmaceuticals, an Australia-based clinical-stage radiopharmaceutical company with a mission to develop ne...

March 26, 2026 | Thursday | News
Cytiva and Yoshindo advance domestic biosimilar manufacturing in Japan

Cytiva, a Danaher company and a leader in the life sciences industry, has signed a FlexFactory™ contract with Yosh...

March 24, 2026 | Tuesday | News
Sandoz announces biosimilars partnership agreement with Korea's Samsung Bioepis

Sandoz, the global leader in affordable medicines, has announced a major license, development and commercialisation part...

March 21, 2026 | Saturday | News
Japan's Fujifilm invests in Valanx Biotech to strengthen ADC CDMO capabilities

Japan-based Fujifilm Corporation has announced its investment in Valanx Biotech, an Austrian biotechnology company with ...

March 18, 2026 | Wednesday | News
Australia's BioCina initiates comprehensive manufacturing programme for delirium treatment

Australia-based startup BioCina, a global end-to-end Contract Development and Manufacturing Organisation (CDMO), ha...

March 17, 2026 | Tuesday | News
Translating Cell And Gene Therapy Innovation Into Scalable Manufacturing Requires Early Strategic Planning

On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...

March 13, 2026 | Friday | News
Singapore Strengthens Its Position As A Trusted Hub For Global Biopharmaceutical Manufacturing

On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...

March 13, 2026 | Friday | News